← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2002Last known activity
Feb 1, 2009
Acquired by Paladin Labs → Endo Pharmaceuticals → Mallinckrodt (2013) on Jan 1, 2011
Timeline
1990s
- Jan 1, 1990
Labopharm— Founded
2010s
- Jan 1, 2011
Paladin Labs— Acquired By
2020s
- Mar 1, 2025
Mallinckrodt (2013)— Now
Drugs by trial phase (3 distinct, 20 trials)
Phase 3 (3 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT00839072Lead sponsorPhase 1Feb 1, 2009
- NCT01121900Lead sponsorPhase 1Jun 1, 2008
- NCT00973232Lead sponsorPhase 1May 1, 2008
- NCT00643383Lead sponsorPhase 3Mar 1, 2008
- NCT01121926Lead sponsorPhase 1Jan 1, 2008
- NCT00775203Lead sponsorPhase 3Jun 1, 2007
- NCT02329561CollaboratorPhase 1Jan 1, 2007
- NCT00952068Lead sponsorPhase 2Jan 1, 2007
- NCT00834912Lead sponsorPhase 1Feb 1, 2006
- NCT01121913Lead sponsorPhase 1Mar 1, 2005
- NCT00834366Lead sponsorPhase 1Feb 1, 2005
- NCT00833794Lead sponsorPhase 3Oct 1, 2004
- NCT00911742Lead sponsorPhase 1Feb 1, 2004
- NCT00834288Lead sponsorPhase 1Jun 1, 2003
- NCT00833911Lead sponsorPhase 3Apr 1, 2003
Details
- Founded
- Quebec, CA Jan 1, 1990
- Last known activity
- Feb 1, 2009
Notes
Acquired by Paladin Labs 17 Aug 2011